Palisade Bio (PALI) Operating Expenses (2010 - 2026)

Palisade Bio (PALI) has 17 years of Operating Expenses data on file, last reported at $10.7 million in Q1 2026.

• Operating Expenses for Q1 2026 came in at $10.7 million, up 365.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $26.5 million (up 96.31% YoY), and the FY2025 annual result was $18.1 million, up 21.52% from the prior year.
• Operating Expenses grew to $10.7 million in Q1 2026 per PALI's latest filing, from $10.0 million in the prior quarter.
• Over five years, Operating Expenses peaked at $10.7 million in Q1 2026 and troughed at $2.3 million in Q1 2025.
• A 5-year average of $4.3 million and a median of $3.6 million in 2023 frame the typical range for Operating Expenses.
• The sharpest annual moves came in 2022 and 2026: Operating Expenses tumbled 89.13% in 2022, then surged 365.28% in 2026.
• A 5-year view of Operating Expenses shows it stood at $3.8 million in 2022, then dropped by 18.04% to $3.2 million in 2023, then increased by 7.23% to $3.4 million in 2024, then jumped by 195.12% to $10.0 million in 2025, then increased by 7.68% to $10.7 million in 2026.
• Business Quant data shows PALI's Operating Expenses at $10.7 million in Q1 2026, $10.0 million in Q4 2025, and $2.9 million in Q3 2025.